As I'm writing this blog post on July 29th, it's expected to reach a high of 77 degrees Fahrenheit today while also being sunny. And temperatures won't be much hotter than that over the next couple of days here in Central Wisconsin. This perfect weather is precisely why I will be spending at least several hours outside this weekend.
With that out of the way, the timing of the month means that it's time to check out my stock purchases for July 2022.
I started off the month of July by purchasing eight shares of VICI Properties (VICI) at an average cost of $30.02 a share. Readers interested in a more detailed explanation of this dividend stock purchase can check out my Motley Fool article on the stock and Medical Properties Trust (MPW) that was published a few weeks ago. This transaction added $11.52 in net annual forward dividends to my portfolio.
The next dividend stock that I added to during the month was Merck (MRK). I picked up an additional three shares of the stock at a cost per share of $90.83. My reasons for scooping up more shares of MRK can be found in this Motley Fool article from June on the stock and Amgen (AMGN). As a result of this purchase, my net annual forward dividends surged $8.28 higher.
I also snatched up five units of Magellan Midstream Partners (MMP) in July at an average cost of $46.62 per unit. It has been a while since I have covered MMP, but my buying rationale remains the same compared to this Motley Fool article from last December. Due to this transaction, my net annual forward distributions soared higher by $20.75.
The fourth dividend stock that I picked up during the month was British American Tobacco (BTI). I increased my position by six shares at an average cost per share of $40.43. For my rationale on executing this transaction, I would refer interested readers to my recent Motley Fool article on the stock and Leggett & Platt (LEG). As a result of this purchase, my net annual forward dividends vaulted $17.82 higher.
I also scooped up five shares of Iron Mountain (IRM) in July at an average cost of $48.32 a share. For my buying rationale on IRM and why I also like American Tower (AMT), readers can take a peek at this Motley Fool article. This purchase boosted my net annual forward dividends by $12.37.
The sixth dividend stock that I added to during the month was Mastercard (MA). I increased my position by one share at a total cost of $320.73. As I alluded to in a recently published Motley Fool article on Visa (V) and MA, the latter should continue to be an especially promising wealth compounder in the future. This helped my net annual forward dividends edge $1.96 higher.
I also picked up five more shares of ONEOK (OKE) in July at an average cost of $55.29 a share. This lifted my net annual forward dividends by $18.70.
The eighth stock that I purchased during the month was another share of Amazon (AMZN) at a cost of $110.07. As I explained a few months back, AMZN is an e-commerce, advertising, and cloud computing juggernaut. It probably won't be paying a dividend until the end of this decade or the start of next decade. But by the time it does, it will likely be at least a 5-bagger from my current cost basis.
Speaking of advertising giants, I initiated a six share position in Alphabet (GOOGL) in July at an average cost of $111.40 a share. The parent company to Google and YouTube is the undisputed leader of digital advertising. GOOGL boasted a 28.6% market share in 2021, which was meaningfully ahead of Facebook (FB) at 23.8% and AMZN at 11.3%.
This significant competitive advantage is why analysts believe GOOGL will deliver 13.7% annual earnings growth over the next five years. And at a current year P/E ratio of 21.5, the stock is trading at an attractive valuation for the long haul. Similar to AMZN, I believe GOOGL will be a powerful dividend payer in due time. In the meantime, the capital gains should be spectacular.
I deployed $2,605.52 in capital during the month of July across a wide array of stocks. High growth stock purchases like AMZN, GOOGL, and MA will be grand slam dividend growers in 2030 and beyond in my opinion. And my midstream, REIT, tobacco, and pharma additions will provide both significant immediate and future income.
My stock purchases for the month added $91.40 in net annual forward dividends to my portfolio, which is a 3.51% weighted average dividend yield. Dividend increases received in July chipped in another $16.22 to my net annual forward dividends. This led my portfolio's net annual forward dividends to spike from just over $2,960 at the start of the month to a bit less than $3,070 heading into August.
How was your July 2022 for stock purchases?
Did you add any new holdings to your portfolio like I did with my purchase of GOOGL?
I appreciate your readership and welcome your comments below!